Senators Cassidy and Carper Call for Medicare to Cover Obesity Drugs Amid COVID-19 Pandemic
Statement on metabolic and bariatric surgery during COVID-19 pandemic.
Evidence-based prediction tool designed to help patients decide between metabolic surgery and standard medical therapy.
Patients who have surgery before obesity progresses to severe stages may achieve even greater health benefits.
New study compares differences in cancer risk reduction among weight-loss surgery patients
Patients with history of heart disease reduce their risk by half
Overweight and obesity associated with an increased risk of 13 types of cancer
Patients with severe obesity who get weight-loss surgery cut their spending on diabetes medications by nearly 65 percent and spending on high blood pressure medications by more than a third three to six months after the operation, according to new research from Rush Medical College in Chicago presented here at an American Society for Metabolic and Bariatric Surgery (ASMBS) national clinical symposium on obesity prevention, treatment and research.
Metabolic or bariatric surgery was significantly more effective than medical management in treating type 2 diabetes in patients with milder forms of obesity, according to new research presented here at an American Society for Metabolic and Bariatric Surgery (ASMBS) national clinical symposium on obesity prevention, treatment and research.
West Virginia and Mississippi may have the two highest obesity rates in the nation but rank 25th and 45th in the country when it comes to the number of weight-loss surgeries per capita, and have two of the worst state economies, according to a new analysis of factors that may determine utilization of bariatric surgery in the 50 states plus the nation’s capital.